Justin D. Pitt - 15 Mar 2024 Form 4 Insider Report for COMMUNITY HEALTH SYSTEMS INC (CYH)

Signature
Christopher G. Cobb, Attorney in Fact for Justin D. Pitt
Issuer symbol
CYH
Transactions as of
15 Mar 2024
Net transactions value
$0
Form type
4
Filing time
15 Mar 2024, 16:31:47 UTC
Previous filing
01 Mar 2024
Next filing
03 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYH Common Stock Disposed to Issuer $0 -5,001 -28% $0.000000 12,584 15 Mar 2024 By spouse F1
holding CYH Common Stock 208,116 15 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CYH Performance Based Restricted 30,000 15 Mar 2024 Common Stock 30,000 $0.000000 Direct F2
holding CYH Performance Based Restricted 30,000 15 Mar 2024 Common Stock 30,000 $0.000000 Direct F3
holding CYH Performance Based Restricted 30,000 15 Mar 2024 Common Stock 30,000 $0.000000 Direct F4
holding CYH Stock Options (Right to Buy) 5,000 15 Mar 2024 Common Stock 5,000 $4.99 Direct
holding CYH Stock Options (Right to Buy) 20,000 15 Mar 2024 Common Stock 20,000 $4.93 Direct
holding CYH Stock Options (Right to Buy) 20,000 15 Mar 2024 Common Stock 20,000 $8.81 Direct
holding CYH Stock Options (Right to Buy) 30,000 15 Mar 2024 Common Stock 30,000 $10.18 Direct F5
holding CYH Stock Options (Right to Buy) 30,000 15 Mar 2024 Common Stock 30,000 $6.15 Direct F5
holding CYH Stock Options (Right to Buy) 30,000 15 Mar 2024 Common Stock 30,000 $2.87 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person's spouse is no longer employed by an affiliate of the Issuer. The remaining unvested portion of her prior awards of restricted stock was forfeited in conjunction with her ceasing to be employed by an affiate of the Issuer. The Reporting Person disclaims beneficial ownership of the securities of the Issuer owned by his spouse, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2 The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.
F3 The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.
F4 The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
F5 Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.